A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients with Advanced or Metastatic Solid Tumors

Clinical trial NCT05983523 · RECRUITING

Trial details

NCT number: NCT05983523
Sponsor: PharmaEngine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor Metastatic Solid Tumor

Start date: 2024-03-27
Primary completion: 2027-02-25
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.